Daniel Spinks

1.2k citations

22 papers · 747 indexed · h-index 16

Impact in

Organic Chemistry top 10%
- Synthesis and Biological Evaluation
- Synthesis and biological activity
Public Health, Environmental and Occupational Health top 10%
- Research on Leishmaniasis Studies

Papers in ⓘ

Toxicology 2
Organic Chemistry 13
- Synthesis and Biological Evaluation 6
- Chemical synthesis and alkaloids 3

Co-authors: Alan H. Fairlamb (9 shared papers)Ian H. Gilbert (10 shared papers)Paul G. Wyatt (10 shared papers)Julie A. Frearson (9 shared papers)Stephen Thompson (4 shared papers)Leah S. Torrie (4 shared papers)Ruth Brenk (5 shared papers)Susan Wyllie (2 shared papers)
Journals: ChemMedChem (5 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Journal of Medicinal Chemistry (3 papers)Biochemical Society Transactions (2 papers)Molecular Microbiology (1 paper)
Partner nations: United Kingdom Norway Switzerland

In The Last Decade

Daniel Spinks

22 papers receiving 735 citations

Peers

Countries citing papers authored by Daniel Spinks

Since Specialization

Citations

This map shows the geographic impact of Daniel Spinks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Spinks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Spinks more than expected).

Fields of papers citing papers by Daniel Spinks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Spinks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Spinks. The network helps show where Daniel Spinks may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Spinks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Spinks Line = papers co-authored together Daniel Spinks links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Discovery of a Novel Class of Orally Active Trypanocidal N-Myristoyltransferase Inhibitors Journal of Medicinal Chemistry ·Stephen Brand, Laura A. T. Cleghorn, Stuart P. McElroy, David A. Robinson, Victoria Smith, Irene Hallyburton, Justin R. Harrison, Neil R. Norcross, Daniel Spinks, Tracy Bayliss, Suzanne Norval, Laste Stojanovski, Leah S. Torrie, Julie A. Frearson, Ruth Brenk, Alan H. Fairlamb, Michael A. J. Ferguson, Kevin D. Read, Paul G. Wyatt, Ian H. Gilbert	2011	93
2	One Scaffold, Three Binding Modes: Novel and Selective Pteridine Reductase 1 Inhibitors Derived from Fragment Hits Discovered by Virtual Screening Journal of Medicinal Chemistry ·Chidochangu P. Mpamhanga, Daniel Spinks, L.B. Tulloch, Emma Shanks, David A. Robinson, Iain T. Collie, Alan H. Fairlamb, Paul G. Wyatt, Julie A. Frearson, William N. Hunter, Ian H. Gilbert, Ruth Brenk	2009	83
3	Serotonin Reuptake Inhibition: An Update on Current Research Strategies Current Medicinal Chemistry ·Daniel Spinks, G. Spinks	2002	70
4	Cyclic nucleotide signalling: a molecular approach to drug discovery for Alzheimer's disease Biochemical Society Transactions ·Lydia Gibson, Ian McPhee, J. Kewney, C. Darroch, PA Stevens, Daniel Spinks, Ann Cooreman, Simon J. MacKenzie	2005	63
5	Chemical Validation of Trypanothione Synthetase Journal of Biological Chemistry ·Leah S. Torrie, Susan Wyllie, Daniel Spinks, Sandra L. Oza, Stephen Thompson, Justin R. Harrison, Ian H. Gilbert, Paul G. Wyatt, Alan H. Fairlamb, Julie A. Frearson	2009	62
6	Dissecting the essentiality of the bifunctional trypanothione synthetase‐amidase in Trypanosoma brucei using chemical and genetic methods Molecular Microbiology ·Susan Wyllie, Sandra L. Oza, Stephen Patterson, Daniel Spinks, Stephen Thompson, Alan H. Fairlamb	2009	59
7	4-(Phenylsulfonyl)piperidines: Novel, Selective, and Bioavailable 5-HT_2AReceptor Antagonists Journal of Medicinal Chemistry ·Stephen R. Fletcher, Frank Burkamp, Peter Blurton, Susan K. F. Cheng, R.B. Clarkson, Desmond O’Connor, Daniel Spinks, Matthew T. Tudge, Monique B. van Niel, Smita S. Patel, Kerry L. Chapman, Rose Marwood, Sara L. Shepheard, Graham Bentley, Gina P Cook, Linda J. Bristow, José L. Castro, Peter H. Hutson, Angus M. MacLeod	2001	44
8	Investigation of Trypanothione Reductase as a Drug Target in Trypanosoma brucei ChemMedChem ·Daniel Spinks, Emma Shanks, Laura A. T. Cleghorn, Stuart P. McElroy, Deuan C. Jones, Daniel James, Alan H. Fairlamb, Julie A. Frearson, Paul G. Wyatt, Ian H. Gilbert	2009	43
9	Cyclic nucleotide signalling: a molecular approach to drug discovery for Alzheimer's disease Biochemical Society Transactions ·Ian McPhee, Lydia Gibson, J. Kewney, C. Darroch, PA Stevens, Daniel Spinks, Ann Cooreman, Simon J. MacKenzie	2005	42
10	Design, Synthesis and Biological Evaluation of Trypanosoma brucei Trypanothione Synthetase Inhibitors ChemMedChem ·Daniel Spinks, Leah S. Torrie, Stephen Thompson, Justin R. Harrison, Julie A. Frearson, Kevin D. Read, Alan H. Fairlamb, Paul G. Wyatt, Ian H. Gilbert	2011	36
11	Design, Synthesis and Biological Evaluation of Novel Inhibitors of Trypanosoma brucei Pteridine Reductase 1 ChemMedChem ·Daniel Spinks, Han B. Ong, Chidochangu P. Mpamhanga, Emma Shanks, David A. Robinson, Iain T. Collie, Kevin D. Read, Julie A. Frearson, Paul G. Wyatt, Ruth Brenk, Alan H. Fairlamb, Ian H. Gilbert	2010	32
12	2-Aryl-3,3,3-trifluoro-2-hydroxypropionic acids: A new class of protein tyrosine phosphatase 1B inhibitors Bioorganic & Medicinal Chemistry Letters ·David R. Adams, Achamma Abraham, Jun Asano, Catherine Breslin, Colin A.J. Dick, Ulrich Ixkes, Blair F. Johnston, Derek Johnston, Justin Kewnay, Simon P. Mackay, Simon J. MacKenzie, Morag McFarlane, Lee Mitchell, Daniel Spinks, Yasuo Takano	2007	26
13	Biaryl acids: Novel non-nucleoside inhibitors of HIV reverse transcriptase types 1 and 2 Bioorganic & Medicinal Chemistry Letters ·J. Milton, Matthew James Slater, Amanda Bird, Daniel Spinks, G. B. Scott, C. E. Price, Sylvia J. Downing, Darren V. S. Green, Shalom Madar, Richard C. Bethell, D.K. Stammers	1998	21
14	Development of Small‐Molecule Trypanosoma brucei N‐Myristoyltransferase Inhibitors: Discovery and Optimisation of a Novel Binding Mode ChemMedChem ·Daniel Spinks, Victoria Smith, Stephen Thompson, David A. Robinson, Torsten Luksch, Alasdair Smith, Leah S. Torrie, Stuart P. McElroy, Laste Stojanovski, Suzanne Norval, Iain T. Collie, Irene Hallyburton, Bhavya Rao, Stephen Brand, Ruth Brenk, Julie A. Frearson, Kevin D. Read, Paul G. Wyatt, Ian H. Gilbert	2015	18
15	Screening a protein kinase inhibitor library against Plasmodium falciparum Malaria Journal ·Irene Hallyburton, Raffaella Grimaldi, Andrew Woodland, Beatriz Baragaña, Torsten Luksch, Daniel Spinks, Daniel James, Didier Leroy, David Waterson, Alan H. Fairlamb, Paul G. Wyatt, Ian H. Gilbert, Julie A. Frearson	2017	16
16	Microwave promoted amination of 3-bromoisoxazoles Tetrahedron Letters ·Jane E. Moore, Daniel Spinks, Joseph P. A. Harrity	2004	16
17	The discovery and SAR of indoline-3-carboxamides—A new series of 5-HT6 antagonists Bioorganic & Medicinal Chemistry Letters ·Mark Reid, Ian Carlyle, Wilson Caulfield, Tom Clarkson, Fiona Cusick, Ola Epemolu, Robert F. Gilfillan, Richard Goodwin, David Jaap, Elise C. O’Donnell, Jeremy Presland, Zoran Ranković, Daniel Spinks, Gayle Spinks, Anne M. Thomson, Fiona Thomson, James Strain, Grant Wishart	2010	6
18	Optimisation of the Anti‐Trypanosoma brucei Activity of the Opioid Agonist U50488 ChemMedChem ·Victoria Smith, Laura A. T. Cleghorn, Andrew Woodland, Daniel Spinks, Irene Hallyburton, Iain T. Collie, N. Yi Mok, Suzanne Norval, Ruth Brenk, Alan H. Fairlamb, Julie A. Frearson, Kevin D. Read, Ian H. Gilbert, Paul G. Wyatt	2011	6
19	2,4-Diamino-6-methylpyrimidines for the potential treatment of Chagas’ disease Bioorganic & Medicinal Chemistry Letters ·Michael G. Thomas, Manu De Rycker, Ignacio Cotillo Torrejon, John Thomas, Jennifer Riley, Daniel Spinks, Kevin D. Read, Tim J. Miles, Ian H. Gilbert, Paul G. Wyatt	2018	4
20	Serotonin Reuptake Inhibition: An Update on Current Research Strategies Daniel Spinks, G. Spinks	2004	4

About Daniel Spinks

Daniel Spinks is a scholar working on Toxicology, Organic Chemistry, Pharmaceutical Science, Public Health, Environmental and Occupational Health and Epidemiology, having authored 22 papers that have together received 747 indexed citations. Recurring topics across this work include Trypanosoma species research and implications (10 papers), Research on Leishmaniasis Studies (8 papers), Synthesis and Biological Evaluation (6 papers), Pharmacological Receptor Mechanisms and Effects (4 papers), Enzyme function and inhibition (4 papers), Chemical Synthesis and Analysis (3 papers), Chemical synthesis and alkaloids (3 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). The work is most often cited by research in Organic Chemistry (267 citations), Public Health, Environmental and Occupational Health (264 citations), Epidemiology (288 citations), Toxicology (27 citations) and Parasitology (45 citations). Daniel Spinks has collaborated with scholars based in United Kingdom, Norway and Switzerland. Frequent co-authors include Alan H. Fairlamb, Ian H. Gilbert, Paul G. Wyatt, Julie A. Frearson, Stephen Thompson, Leah S. Torrie, Ruth Brenk, Susan Wyllie, Sandra L. Oza and Justin R. Harrison. Their work appears in journals such as ChemMedChem, Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Biochemical Society Transactions and Molecular Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact